John Wiley & Sons, Inc., announced today the launch of a new open
access, interdisciplinary journal providing rapid publication of
cutting-edge research across the broad field of immunology.
Immunity, Inflammation and Disease, the latest journal to be launched
from the Wiley Open Access program, is supported by a number of major
societies; British Society for Immunology; European Federation of
Immunological Societies; European Academy of Allergy and Clinical
Immunology; and the British Society for Allergy and Clinical Immunology,
as well as leading journals in the field, including Allergy (Impact
Factor 6.3), European Journal of Immunology (Impact Factor 5.1) and
Clinical and Experimental Allergy (Impact Factor 5.0).
All articles in Immunity, Inflammation and Disease will be published
open access under the Creative Commons Attribution (CC-BY) License on
Wiley Online Library and deposited in PubMed Central immediately upon
publication. A publication fee will be payable by authors on acceptance
of their articles. Authors affiliated with, or funded by, an
organization that has a Wiley Open Access Account can publish without
directly paying any publication charges.
Marc Veldhoen, a group leader at the Babraham Institute in
Cambridgeshire, UK, has been appointed as Editor-in-Chief for the new
journal. Dr. Veldhoen studied Medical Biology at the Faculty of
Medicine, Utrecht University, The Netherlands and went on to pursue his
post doctorate at the National Institute for Medical Research Mill Hill,
UK.
“It is my hope and goal with Immunity, Inflammation and Disease to make
a contribution towards quality open access scientific publishing and to
stimulate debate. Being part of Wiley means we will make full use of its
experience with quality peer reviewed scientific publishing,” said Dr.
Veldhoen. “My aims are to shape it into a high quality journal
publishing new and original data, and to encourage the preservation of
the original scientific method of open discussion and frank exchange of
thoughts and ideas.”
“We are delighted to be launching this new open access journal in
immunology, particularly with support of our long term publishing
partners which will be invaluable in ensuring that the new journal goes
from strength to strength,” said Bob Campbell, Senior Publisher, Wiley.
The journal is open to submissions now. Visit the journal’s website www.immunityinflammationdisease.com
for further information and future updates.
About Wiley Open Access:
Wiley
Open Access is an initiative from Wiley to drive quality peer reviewed
publishing with speed and efficiency through open access publication.
All research articles published in Wiley Open Access journals are
immediately freely available to read, download and share. The fully open
access journals are published in collaboration with authoritative
journals and societies as well as supported by internationally renowned
editorial board members. For more information, please visit http://www.wileyopenaccess.com.
About Wiley
Wiley is a global
provider of content-enabled solutions that improve outcomes in research,
education, and professional practice. Our core businesses produce
scientific, technical, medical, and scholarly journals, reference works,
books, database services, and advertising; professional books,
subscription products, certification and training services and online
applications; and education content and services including integrated
online teaching and learning resources for undergraduate and graduate
students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a
valued source of information and understanding for more than 200 years,
helping people around the world meet their needs and fulfill their
aspirations. Wiley and its acquired companies have published the works
of more than 450 Nobel laureates in all categories: Literature,
Economics, Physiology or Medicine, Physics, Chemistry, and Peace.
Wiley's global headquarters are located in Hoboken, New Jersey, with
operations in the U.S., Europe, Asia, Canada, and Australia. The
Company's website can be accessed at http://www.wiley.com.
